Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by lscfaon Apr 01, 2024 5:32pm
213 Views
Post# 35963746

OXYGEN BILL INTRODUCED IN HOUSE

OXYGEN BILL INTRODUCED IN HOUSE

HME News Staff

Updated 9:53 AM CDT, Mon April 1, 2024

 

WASHINGTON – A bill to reform the home oxygen therapy benefit has now also been introduced in the U.S. House of Representatives. 

The Supplemental Oxygen Access Reform (SOAR) Act, H.R. 7829, introduced by Reps. David Valadao, R-Calif.; Julia Brownley, D-Calif.; Larry Bucshon, R-Ind., and Adrian Smith, R-Neb., would: 

  • Remove supplemental oxygen from Medicare’s competitive bidding program 

  • Permanently extend Medicare’s blended reimbursement rates 

  • Establish a separate payment system for liquid oxygen  

  • Reimburse for respiratory therapist services 

  • Mandate the use of a template for documentation 

“CQRC applauds Representatives Valadao, Brownley, Bucshon, and Smith for their leadership on this important bill and calls upon Congress to support comprehensive oxygen reform,” said Dan Starck, interim chair of the Council for Quality Respiratory Care. “Doing so will help protect access to respiratory care for patients. CQRC is proud to advocate for this bill alongside patients, family advocates, physicians, and providers, and we urge lawmakers to pass the SOAR Act.”   

Sens. Bill Cassidy, MD., R-La., Mark Warner, D-Va., and Amy Klobuchar, D-Minn., introduced a similar bill in the Senate earlier this year.

<< Previous
Bullboard Posts
Next >>